SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPorvair Regulatory News (PRV)

Share Price Information for Porvair (PRV)

Share Price is delayed by 15 minutes
Get Live Data
830.00    14.00 (1.72%)
Bid:
824.00
Ask:
828.00
Spread: 4.00 (0.485%)
Market Cap: £382.60m
PRV Live PriceLast checked at - London Stock Exchange

Intraday Porvair Share Chart

Trading update

2 Dec 2009 07:00

RNS Number : 4289D
Porvair PLC
02 December 2009
Β 

ο»Ώ

For immediate release 2 December 2009

Porvair plc ("Porvair" or "The Group")

Trading update

Porvair, the specialist filtration and environmental technologies group, makes the followingΒ update regardingΒ trading in theΒ year ended 30Β NovemberΒ 2009:

TheΒ BoardΒ expects to report results in line with expectations for the year.Β InΒ what has been a very difficult economic environment, Porvair expects toΒ not onlyΒ achieve its sales and profit targetsΒ but toΒ exceed its cash generation expectations.Β Β Net debt isΒ anticipatedΒ to beΒ better than expectations and to have reduced by over Β£2m in the year to less than Β£14.5m.

Microfiltration

The Microfiltration division, which servesΒ theΒ aviation, energy, clean water and industrialΒ markets, hasΒ continued to trade as expected. Seal Analytical, acquired in 2008, has had a good first full year in the Group;Β generatingΒ improvedΒ profitsΒ and anΒ attractiveΒ cash return. Before the impact ofΒ theΒ 2008Β Seal acquisition, like-for-likeΒ divisionalΒ salesΒ for 2009Β areΒ expected to beΒ aroundΒ 10% lower than the prior year -Β a resilient performanceΒ in challenging circumstances.Β Β The MicrofiltrationΒ divisionΒ has a goodΒ near term pipeline of orders.

Metals Filtration

As previously reported, Selee Corp., the largest part of the Metals Filtration division, underwent a severe restructuring programmeΒ in the second quarterΒ in response toΒ market demand that fell on average byΒ 35%.Β Β One-off restructuring costs were reported in the interim statement in June 2009.Β Β Since these actions,Β SeleeΒ hasΒ returned toΒ modest profitabilityΒ andΒ generatedΒ cash. In the final quarter of the year sales per day have improved, with aluminiumΒ filter demandΒ benefiting fromΒ the 80% of currentΒ customersΒ who have now switched to a newΒ proprietary filterΒ developed by Selee.Β Β 

Outlook

Β 

Looking ahead, the Board’s planning assumption is that the difficult economic climate will continue throughout 2010, however the near term order book is encouraging.Β The Board’s view is that the steady improvement in Selee’s trading; the market acceptance of its new proprietary aluminium and iron foundry filters; a strengthening order book in Microfiltration; and the Group’s proven cash generating ability give grounds for cautious optimism. The Board does not believe that the recent share price weakness reflects this.

Β 

The Company will be announcing its preliminary results for theΒ year endedΒ 30 November 2009 on Tuesday 26 January 2010.

For further information, please contact:

Porvair plc

01553 765 500

Ben Stocks, Chief Executive

Chris Tyler, Group Finance Director

Β 

Buchanan Communications

0207 466 5000

Charles Ryland /Β Catherine Breen

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTVFLFBKLBFFBX
Date   Source Headline
27th Mar 20257:00 amRNSGrant of SAYE Options
18th Mar 20257:40 amRNSHolding(s) in Company
17th Mar 20253:30 pmRNSHolding(s) in Company
14th Mar 20257:00 amRNSNotice of Annual General Meeting; Accounts posting
4th Mar 20253:00 pmRNSHolding(s) in Company
12th Feb 20252:30 pmRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSFull Year Results
12th Dec 20241:00 pmRNSHolding(s) in Company
10th Dec 20247:00 amRNSTrading update and notice of results
2nd Dec 20243:01 pmRNSTotal Voting Rights
2nd Dec 20243:00 pmRNSDirector/PDMR Shareholding
25th Nov 20244:37 pmRNSShareholder Communications
28th Oct 20247:00 amRNSBoard appointment
1st Oct 20247:00 amRNSTotal Voting Rights
23rd Sep 20247:00 amRNSAppointment of Chief Executive Officer
2nd Sep 20245:15 pmRNSDirector/PDMR Shareholding
2nd Sep 20245:00 pmRNSTotal Voting Rights
31st Jul 202410:45 amRNSTotal Voting Rights
31st Jul 202410:30 amRNSBlock listing Interim Review
29th Jul 20246:15 pmRNSDirector/PDMR Shareholding
1st Jul 20247:00 amRNSInterim Results
27th Jun 20242:26 pmRNSDirector/PDMR Shareholding
23rd Apr 20241:38 pmRNSDirector/PDMR Shareholding
16th Apr 20242:56 pmRNSAGM Results Announcement
16th Apr 20247:00 amRNSAGM Trading Update & Board Update
3rd Apr 20247:00 amRNSDirector resignation
12th Mar 20247:00 amRNSDirector declaration
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20244:41 pmRNSHolding(s) in Company
8th Feb 20244:27 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSResults for the year ended 30 November 2023
1st Feb 20247:00 amRNSBlock listing Interim Review
19th Dec 202310:25 amRNSHolding(s) in Company
5th Dec 20237:00 amRNSTrading Update & Acquisition
4th Dec 202312:00 pmRNSHolding(s) in Company
25th Sep 202310:00 amRNSDirector/PDMR Shareholding
12th Sep 20237:00 amRNSNine Month Trading Update
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
17th Jul 20237:00 amRNSAcquisition completion
7th Jul 20234:00 pmRNSBlock Listing Application
3rd Jul 20237:00 amRNSInterim Results
26th Jun 20237:00 amRNSBoard Change
21st Jun 20234:22 pmRNSHolding(s) in Company
21st Jun 20237:00 amRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSBlock listing Interim Review
4th May 20237:00 amRNSAcquisitions
18th Apr 202312:51 pmRNSAGM resolutions
18th Apr 20237:00 amRNSAGM Trading Update
31st Mar 20234:00 pmRNSTotal Voting Rights
22nd Mar 20233:03 pmRNSGrant of options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.